The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
We are building an AI-native operating system for pharma sales and distribution
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Subscribe To Our Newsletter & Stay Updated
